Open-Label Extension Study of ASTORIA

NCT05516875 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped The trial is terminated based on business decision, not due to safety concerns or regulatory requirements.

Conditions

Dyskinesias

Interventions

DRUG: JM-010

Sponsor

Contera Pharma A/S